Radiotherapy News and Research

RSS
Radiation therapy (in North America), or radiotherapy (in the UK and Australia) also called radiation oncology, and sometimes abbreviated to XRT, is the medical use of ionizing radiation as part of cancer treatment to control malignant cells (not to be confused with radiology, the use of radiation in medical imaging and diagnosis).
RapidArc radiotherapy technology delivers highly-precise IMRT treatment

RapidArc radiotherapy technology delivers highly-precise IMRT treatment

Varian Medical Systems' RapidArc radiotherapy enables faster stereotactic treatment of lung tumors

Varian Medical Systems' RapidArc radiotherapy enables faster stereotactic treatment of lung tumors

University of Navarra Hospital launches clinical trials to assess the efficacy of immunotherapy treatment

University of Navarra Hospital launches clinical trials to assess the efficacy of immunotherapy treatment

Clinical trials of personalised vaccines to fight glioblastomas

Clinical trials of personalised vaccines to fight glioblastomas

MagForce Nanotechnologies initiates conformity assessment procedure for its Nano-Cancer therapy

MagForce Nanotechnologies initiates conformity assessment procedure for its Nano-Cancer therapy

Siemens Healthcare to introduce high-end imaging systems for interventional oncological procedures at RSNA 2009

Siemens Healthcare to introduce high-end imaging systems for interventional oncological procedures at RSNA 2009

Varian Medical Systems to exhibit its full range of detectors at RSNA Annual Meeting in Chicago

Varian Medical Systems to exhibit its full range of detectors at RSNA Annual Meeting in Chicago

Study on response to breast cancer radiotherapy

Study on response to breast cancer radiotherapy

'Suicide gene E' reduces potent drug dosage in cancer patients

'Suicide gene E' reduces potent drug dosage in cancer patients

Initiation of Phase II clinical trial to evaluate the efficacy of BN83495 announced

Initiation of Phase II clinical trial to evaluate the efficacy of BN83495 announced

Ohr Pharmaceutical to develop OHR/AVR118 for cachexia treatment

Ohr Pharmaceutical to develop OHR/AVR118 for cachexia treatment

U.S. Court rules in Merck's favor in Flemings case involving FOSAMAX

U.S. Court rules in Merck's favor in Flemings case involving FOSAMAX

Initiation of Phase I/IIa clinical trial of IL-7 announced

Initiation of Phase I/IIa clinical trial of IL-7 announced

Combination therapy improves survival rates of patients with head and neck cancer

Combination therapy improves survival rates of patients with head and neck cancer

UCH introduces RapidArc technology from Varian Medical Systems

UCH introduces RapidArc technology from Varian Medical Systems

New biomarkers can predict patients' response to certain drugs

New biomarkers can predict patients' response to certain drugs

Queen’s University Belfast to study individualized radiotherapy treatment for breast cancer

Queen’s University Belfast to study individualized radiotherapy treatment for breast cancer

PaxScan digital image detectors and X-ray tubes of Varian Medical Systems to be exhibited

PaxScan digital image detectors and X-ray tubes of Varian Medical Systems to be exhibited

Interim data from an ongoing phase 1 dose-escalation trial of XL147 reported

Interim data from an ongoing phase 1 dose-escalation trial of XL147 reported

Press conference highlights emerging treatments in pancreatic cancer

Press conference highlights emerging treatments in pancreatic cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.